Chase Science Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Chase Science.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Electronic earnings growth | 32.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Chase Science's (SZSE:300941) Weak Earnings May Only Reveal A Part Of The Whole Picture
Nov 05
Chase Science Co., Ltd (SZSE:300941) Stock Rockets 41% As Investors Are Less Pessimistic Than Expected
Sep 30Chase Science's (SZSE:300941) Shareholders Will Receive A Smaller Dividend Than Last Year
Jun 17Investors Could Be Concerned With Chase Science's (SZSE:300941) Returns On Capital
Jun 08More Unpleasant Surprises Could Be In Store For Chase Science Co., Ltd's (SZSE:300941) Shares After Tumbling 25%
Apr 21What Chase Science Co., Ltd's (SZSE:300941) 26% Share Price Gain Is Not Telling You
Mar 04Returns On Capital Signal Tricky Times Ahead For Chase Science (SZSE:300941)
Feb 27In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Chase Science has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 257 | 76 | 39 | 39 | N/A |
| 6/30/2024 | 254 | 75 | 13 | 14 | N/A |
| 3/31/2024 | 256 | 81 | 47 | 48 | N/A |
| 12/31/2023 | 261 | 81 | -2 | -1 | N/A |
| 9/30/2023 | 321 | 91 | 36 | 38 | N/A |
| 6/30/2023 | 344 | 96 | 77 | 79 | N/A |
| 3/31/2023 | 384 | 109 | 82 | 84 | N/A |
| 1/1/2023 | 395 | 111 | 89 | 90 | N/A |
| 9/30/2022 | 381 | 108 | 112 | 114 | N/A |
| 6/30/2022 | 395 | 109 | 108 | 110 | N/A |
| 3/31/2022 | 402 | 107 | 134 | 136 | N/A |
| 1/1/2022 | 420 | 106 | 101 | 102 | N/A |
| 9/30/2021 | 524 | 127 | 116 | 117 | N/A |
| 6/30/2021 | 567 | 137 | 128 | 130 | N/A |
| 3/31/2021 | 629 | 148 | 150 | 152 | N/A |
| 12/31/2020 | 614 | 146 | 155 | 157 | N/A |
| 9/30/2020 | 625 | 137 | 128 | 130 | N/A |
| 6/30/2020 | 605 | 123 | 148 | 149 | N/A |
| 3/31/2020 | 527 | 106 | 59 | 61 | N/A |
| 12/31/2019 | 542 | 100 | 107 | 109 | N/A |
| 9/30/2019 | 496 | 77 | 49 | 51 | N/A |
| 6/30/2019 | 474 | 75 | 50 | 51 | N/A |
| 3/31/2019 | 463 | 69 | 68 | 69 | N/A |
| 1/1/2019 | 407 | 67 | 44 | 44 | N/A |
| 9/30/2018 | 391 | 63 | 40 | 42 | N/A |
| 6/30/2018 | 350 | 59 | N/A | -21 | N/A |
| 3/31/2018 | 318 | 59 | N/A | -7 | N/A |
| 12/31/2017 | 307 | 55 | N/A | 56 | N/A |
| 9/30/2017 | 142 | 36 | N/A | -20 | N/A |
| 6/30/2017 | 161 | 47 | N/A | 40 | N/A |
| 3/31/2017 | 142 | 42 | N/A | 50 | N/A |
| 12/31/2016 | 147 | 44 | N/A | 51 | N/A |
| 9/30/2016 | 134 | 41 | N/A | 42 | N/A |
| 6/30/2016 | 135 | 41 | N/A | 33 | N/A |
| 3/31/2016 | 129 | 37 | N/A | 29 | N/A |
| 1/1/2016 | 115 | 31 | N/A | 24 | N/A |
| 9/30/2015 | 123 | 29 | N/A | 22 | N/A |
| 6/30/2015 | 123 | 25 | N/A | 21 | N/A |
| 3/31/2015 | 128 | 24 | N/A | 13 | N/A |
| 1/1/2015 | 133 | 24 | N/A | 5 | N/A |
| 12/31/2013 | 161 | 16 | N/A | 13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 300941's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 300941's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 300941's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 300941's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 300941's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 300941's Return on Equity is forecast to be high in 3 years time